Physician

Richard M Divalerio, M.D.

According to 2025 Medicare claims, Richard Divalerio, M.D. (NPI: 1841298072) practices rheumatology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from St. Louis, MO. This provider's primary affiliated billing organization is ST LOUIS MEDICAL CLINIC, P.C. (NPI: 1174505127; TIN: 430820801) and primary practice location at 63131-2322. Divalerio is affiliated with the BJC HealthCare ACO, LLC (ACO ID: A1204), IRCCO (ACO ID: A2619), Aledade A2643 Primary Care MSSP Enhanced (ACO ID: A2643), SSM IL ACO, LLC (ACO ID: A4832), and IHCI ACO Midwest LLC (ACO ID: A5516), participating under the MSSP model.

Divalerio's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 429 traditional Medicare patients, billed 149,533 HCPCS/CPT codes, and received $2,275,015 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,031 prescription claims across 601 beneficiaries totaling $2,158,940 in drug costs, led by Rinvoq (Upadacitinib). 2022 DME data shows 96 claims. Open Payments data shows 156 records totaling $2,484. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $673,900 to $2,275,015. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,437,838 and ending at $2,158,940. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $9,226 to $19,719.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	643	25,487	$673,900
2016	674	24,168	$569,092
2017	746	18,540	$459,974
2018	713	69,651	$1,306,201
2019	692	91,684	$1,606,246
2020	597	85,104	$1,668,960
2021	520	102,810	$2,488,334
2022	467	122,131	$2,218,120
2023	471	139,095	$2,035,274
2024	429	149,533	$2,275,015

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	627	10,770	$1,437,838
2016	638	11,431	$1,464,680
2017	693	11,444	$1,504,650
2018	736	11,807	$1,856,530
2019	727	11,319	$1,960,809
2020	716	9,482	$1,601,083
2021	641	6,545	$1,269,878
2022	558	5,428	$1,492,933
2023	596	5,447	$2,036,214
2024	601	6,031	$2,158,940

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	30	341	$110,792
2016	14	150	$4,619
2017	13	84	$2,025
2018	11	62	$789
2019	N/R	56	$1,508
2020	N/R	23	$10,467
2021	N/R	22	$1,356
2022	N/R	96	$44,170
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	259	743	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	240	544	$59
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	63	429	$45
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	237	360	$12
36415	Insertion of needle into vein for collection of blood sample	221	359	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rinvoq	Upadacitinib	78	2,700	$583,732
Humira(Cf) Pen	Adalimumab	33	924	$347,159
Xeljanz Xr	Tofacitinib Citrate	48	1,680	$328,196
Enbrel Sureclick	Etanercept	30	1,176	$325,208
Humira Pen	Adalimumab	24	672	$173,448

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	156	$2,484	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Richard M. Divalerio, M.D.?

Tedicare shows public-source Medicare data for Richard M. Divalerio, M.D. (NPI 1841298072), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard M. Divalerio, M.D. have ACO affiliation data?

Richard M. Divalerio, M.D. is shown with ACO affiliation data for BJC HealthCare ACO, LLC (MSSP, ACO ID A1204), IRCCO (MSSP, ACO ID A2619), Aledade A2643 Primary Care MSSP Enhanced (MSSP, ACO ID A2643), SSM IL ACO, LLC (MSSP, ACO ID A4832), and IHCI ACO Midwest LLC (MSSP, ACO ID A5516).

What billing organization is linked to Richard M. Divalerio, M.D.?

Richard M. Divalerio, M.D. is linked to ST LOUIS MEDICAL CLINIC, P.C. (billing NPI 1174505127) in the available physician profile data.

Does Richard M. Divalerio, M.D. have Open Payments data?

Richard M. Divalerio, M.D. has 156 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.